Adolor Corporation (Nasdaq:ADLR) and GlaxoSmithKline (NYSE:GSK) announced that the U.S. Food and Drug Administration has approved Entereg® (alvimopan) capsules to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.
[read full story]
Medspas of America Inc. (PINKSHEETS: MEDP), www.medspasofamerica.com, announced today that Dr. Jon Bragi Bjarnason, Chief Executive Officer and Founder of Zymetech Inc., www.zymetech.com, has joined the Company's Advisory...
St. Louis Business Journal - by Kelsey Volkmann Gov. Matt Blunt met Thursday with the in an effort to grow Missouri's biotechnology sector. With more than 70 members, the association represents the majority of the Dutch...
At the risk of getting stuck in a rut, there’s more to talk about from Biovest (BVTI). The conference call had critical details about the clinical trial design that bear directly upon the drug’s approvability by the FDA. That...
NEW YORK----OMRIX Biopharmaceuticals, Inc. , a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that it has received a positive opinion for EVICEL™...